Halozyme Therapeutics, Inc. (HALO)

124.37 +1.87 (+1.53%) USD  |  NASDAQ  |  Oct 20, 16:00
127.43 +3.06 (+2.46%) After-Hours: 06:52
More

Halozyme Therapeutics Gross Profit (TTM) : 1.271B for June 30, 2026

Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 1.271B
March 31, 2026 1.160B
December 31, 2025 1.091B
September 30, 2025 979.74M
June 30, 2025 921.38M
March 31, 2025 833.77M
December 31, 2024 784.86M
September 30, 2024 706.65M
June 30, 2024 624.62M
March 31, 2024 603.77M
December 31, 2023 563.12M
September 30, 2023 537.96M
June 30, 2023 531.56M
March 31, 2023 485.44M
December 31, 2022 477.66M
September 30, 2022 423.26M
June 30, 2022 386.03M
March 31, 2022 392.45M
December 31, 2021 361.90M
September 30, 2021 376.91M
June 30, 2021 339.42M
March 31, 2021 275.46M
December 31, 2020 224.23M
September 30, 2020 165.77M
June 30, 2020 129.92M
Date Value
March 31, 2020 116.71M
December 31, 2019 149.45M
September 30, 2019 167.08M
June 30, 2019 168.11M
March 31, 2019 166.21M
December 31, 2018 141.73M
September 30, 2018 269.19M
June 30, 2018 299.66M
March 31, 2018 291.26M
December 31, 2017 285.46M
September 30, 2017 134.39M
June 30, 2017 101.71M
March 31, 2017 100.77M
December 31, 2016 113.48M
September 30, 2016 126.28M
June 30, 2016 118.16M
March 31, 2016 128.38M
December 31, 2015 105.81M
September 30, 2015 86.24M
June 30, 2015 81.11M
March 31, 2015 58.33M
December 31, 2014 52.60M
September 30, 2014 37.33M
June 30, 2014 43.20M
March 31, 2014 43.91M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
AVITA Medical, Inc. 61.68M
Iovance Biotherapeutics, Inc. 120.66M
Merck & Co., Inc. 48.01B
Incyte Corp. 5.320B
Agenus, Inc. 127.32M